# Retatrutide and the kidneys: urine albumin and eGFR

Source: https://pepvault.app/research/retatrutide-heerspink-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Retatrutide](https://pepvault.app/research#retatrutide)

Clinical trial · people

# Retatrutide 12 mg: UACR 37.0% lower vs placebo in type 2 diabetes

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In these trials, higher retatrutide doses were linked to less albumin in the urine, and to higher eGFR in people with obesity but not in people with type 2 diabetes, in groups where most started with normal albumin levels.

- **Kind:** Clinical trial
- **Studied in:** People
- **Published:** 2025
- **Journal:** Kidney Int Rep

## What they tested

The team wanted to know how retatrutide changes kidney measures in people with type 2 diabetes, or with overweight or obesity.

## How the study was done

A post hoc analysis, meaning one planned after the fact, of 2 placebo-controlled trials with doses from 0.5 to 12 mg: 281 people with type 2 diabetes over 36 weeks, with a dulaglutide 1.5 mg comparison group, and 338 people with overweight or obesity but no diabetes over 48 weeks. Everyone had an eGFR (a measure of how well the kidneys filter blood) of at least 45 ml/min per 1.73 m2.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In people with type 2 diabetes, the 12 mg arm had UACR (the urine albumin-to-creatinine ratio, a measure of albumin in the urine) 37.0% lower than placebo at 36 weeks (95% CI: -57.3 to -7.0), while eGFR did not change compared with placebo. In people with overweight or obesity, UACR was 28.0% lower in the 8 mg arm and 31.5% lower in the 12 mg arm than placebo at 48 weeks. In that group, eGFR based on creatinine rose by 5.3 ml/min per 1.73 m2 in the 8 mg arm and 8.5 ml/min per 1.73 m2 in the 12 mg arm, and eGFR based on cystatin C, or on both markers combined, rose by a similar amount.

## What it doesn’t show

This was a post hoc analysis, and most people started with normal albumin levels (median UACR of 13 mg/g and 7 mg/g), so the drop in actual albumin amounts was modest. People with eGFR below 45 were not included.

## The paper

Heerspink et al. The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity. Kidney Int Rep. 2025.

- [PubMed (PMID 40630318)](https://pubmed.ncbi.nlm.nih.gov/40630318/)
- [The paper (DOI 10.1016/j.ekir.2025.03.049)](https://doi.org/10.1016/j.ekir.2025.03.049)

## The compound

- [Retatrutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)

## More studies on Retatrutide

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026) Meta-analysis · people · 2026
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: HbA1c down up to 1.94% in TRANSCEND-T2D-1](https://pepvault.app/research/retatrutide-transcend-t2d-1-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Post hoc analysis](https://pepvault.app/glossary/post-hoc-analysis)

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

## The library

- [Retatrutide](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
